Drawing for NORTHRUP KING

USPTO serial 72049605

NORTHRUP KING

Reviewed by CopyMark Law Group

Reg. 0674020Status 900
Filing date
Status date
Registration date
Feb 17, 1959
Examiner
—
Law office
SCANNING ON DEMAND

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with NORTHRUP KING?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

RICHARD A. FRIEDMAN

RICHARD A FRIEDMAN NOVARTIS PHARMACEUTICALS CORPORATION564 MORRIS AVESUMMIT, NJ 07901-1027UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001FIELD SEEDS INCLUDING SEED CORN, GRASS SEEDS, FLOWER SEEDS, AND VEGETABLE SEEDSEXPIRED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 19, 2009CAEXCANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9—
Oct 21, 2008CFITCASE FILE IN TICRS—
Mar 23, 2001RNL2REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active.
Mar 23, 20019G8PREGISTERED - SEC. 9 GRANTED/CHECK RECORD FOR SEC. 8—
May 30, 2000PRA9RESPONSE RECEIVED TO POST REG. ACTION - SEC. 9—
Feb 22, 2000PRA9POST REGISTRATION ACTION MAILED - SEC. 9—
Mar 3, 19999.AFREGISTERED - SEC. 9 FILED/CHECK RECORD FOR SEC. 8—
Feb 17, 1979REN1REGISTERED AND RENEWED (FIRST RENEWAL - 20 YRS)—

Frequently asked questions

Related guidance